Works matching IS 03407004 AND DT 2004 AND VI 53 AND IP 3

Results: 18

A primer on cancer immunology and immunotherapy.

Published in:

Cancer Immunology, Immunotherapy, 2004, v. 53, n. 3, p. 135, doi. 10.1007/s00262-003-0467-7

By:

Lotze, Michael T.;
Papamichail, Michael

Publication type:

Article

Dendritic cell biology and cancer therapy.

Published in:

Cancer Immunology, Immunotherapy, 2004, v. 53, n. 3, p. 240, doi. 10.1007/s00262-003-0468-6

By:

Whiteside, Theresa L.;
Odoux, Christine

Publication type:

Article

Tumour escape: antitumour effectors too much of a good thing?

Published in:

Cancer Immunology, Immunotherapy, 2004, v. 53, n. 3, p. 262, doi. 10.1007/s00262-003-0469-5

By:

Pawelec, Graham

Publication type:

Article

Identification of tumor antigens as potential target antigens for immunotherapy by serological expression cloning.

Published in:

Cancer Immunology, Immunotherapy, 2004, v. 53, n. 3, p. 144, doi. 10.1007/s00262-003-0470-z

By:

Jäger, Dirk;
Taverna, Christian;
Zippelius, Alfred;
Knuth, Alexander

Publication type:

Article

Identification of tumour antigens by serological analysis of cDNA expression cloning.

Published in:

Cancer Immunology, Immunotherapy, 2004, v. 53, n. 3, p. 139, doi. 10.1007/s00262-003-0471-y

By:

Geng Li;
Miles, Amanda;
Line, Aija;
Rees, Robert C.

Publication type:

Article

Exosome-based immunotherapy.

Published in:

Cancer Immunology, Immunotherapy, 2004, v. 53, n. 3, p. 234, doi. 10.1007/s00262-003-0472-x

By:

Chaput, Nathalie;
Taïeb, Julien;
Schartz, Noël E. C.;
André, Fabrice;
Angevin, Eric;
Zitvogel, Laurence

Publication type:

Article

Monitoring tumor antigen specific T-cell responses in cancer patients and phase I clinical trials of peptide-based vaccination.

Published in:

Cancer Immunology, Immunotherapy, 2004, v. 53, n. 3, p. 249, doi. 10.1007/s00262-003-0473-9

By:

Romero, Pedro;
Cerottini, Jean-Charles;
Speiser, Daniel E.

Publication type:

Article

Apoptosis pathways in cancer and cancer therapy.

Published in:

Cancer Immunology, Immunotherapy, 2004, v. 53, n. 3, p. 153, doi. 10.1007/s00262-003-0474-8

By:

Debatin, Klaus-Michael

Publication type:

Article

Immunobiology of HER-2/neu oncoprotein and its potential application in cancer immunotherapy.

Published in:

Cancer Immunology, Immunotherapy, 2004, v. 53, n. 3, p. 166, doi. 10.1007/s00262-003-0475-7

By:

Baxevanis, Constantin N.;
Sotiropoulou, Panagiota A.;
Sotiriadou, Nectaria N.;
Papamichail, Michael

Publication type:

Article

The use of gene function to identify the rate-limiting steps controlling cell fate.

Published in:

Cancer Immunology, Immunotherapy, 2004, v. 53, n. 3, p. 160, doi. 10.1007/s00262-003-0476-6

By:

Williams, Gwyn T.;
Farzaneh, Farzin

Publication type:

Article

Tetraspanins connect several types of Ig proteins: IgM is a novel component of the tetraspanin web on B-lymphoid cells.

Published in:

Cancer Immunology, Immunotherapy, 2004, v. 53, n. 3, p. 148, doi. 10.1007/s00262-003-0477-5

By:

Le Naour, François;
Charrin, Stéphanie;
Labas, Valérie;
Le Caer, Jean-Pierre;
Boucheix, Claude;
Rubinstein, Eric

Publication type:

Article

Natural killer lymphocytes: biology, development, and function.

Published in:

Cancer Immunology, Immunotherapy, 2004, v. 53, n. 3, p. 176, doi. 10.1007/s00262-003-0478-4

By:

Papamichail, Michael;
Perez, Sonia A.;
Gritzapis, Angelos D.;
Baxevanis, Constantin N.

Publication type:

Article

Identification of tumor antigens and T-cell epitopes, and its clinical application.

Published in:

Cancer Immunology, Immunotherapy, 2004, v. 53, n. 3, p. 196, doi. 10.1007/s00262-003-0479-3

By:

Paschen, Annette;
Eichmuller, Stefan;
Schadendorf, Dirk

Publication type:

Article

The Tübingen approach: identification, selection, and validation of tumor-associated HLA peptides for cancer therapy.

Published in:

Cancer Immunology, Immunotherapy, 2004, v. 53, n. 3, p. 187, doi. 10.1007/s00262-003-0480-x

By:

Singh-Jasuja, Harpreet;
Emmerich, Niels P. N.;
Rammensee, Hans-Georg

Publication type:

Article

Heat shock proteins: biological functions and clinical application as personalized vaccines for human cancer.

Published in:

Cancer Immunology, Immunotherapy, 2004, v. 53, n. 3, p. 227, doi. 10.1007/s00262-003-0481-9

By:

Castelli, Chiara;
Rivoltini, Licia;
Rini, Francesca;
Belli, Filiberto;
Testori, Alessandro;
Maio, Michele;
Mazzaferro, Vincenzo;
Coppa, Jorgelina;
Srivastava, Pramod K.;
Parmiani, Giorgio

Publication type:

Article

Recombinant immunotoxins and retargeted killer cells: employing engineered antibody fragments for tumor-specific targeting of cytotoxic effectors.

Published in:

Cancer Immunology, Immunotherapy, 2004, v. 53, n. 3, p. 217, doi. 10.1007/s00262-003-0482-8

By:

Wels, Winfried;
Biburger, Markus;
Müller, Tina;
Dälken, Benjamin;
Giesübel, Ulrike;
Tonn, Torsten;
Uherek, Christoph

Publication type:

Article

Immunological inhibition of carcinogenesis.

Published in:

Cancer Immunology, Immunotherapy, 2004, v. 53, n. 3, p. 204, doi. 10.1007/s00262-003-0483-7

By:

Spadaro, Michela;
Lanzardo, Stefania;
Curcio, Claudia;
Forni, Guido;
Cavallo, Federica

Publication type:

Article

Identifying biomarkers and surrogates of tumors (cancer biometrics): correlation with immunotherapies and immune cells.

Published in:

Cancer Immunology, Immunotherapy, 2004, v. 53, n. 3, p. 256, doi. 10.1007/s00262-003-0487-3

By:

Lotze, Michael T.;
Rees, Robert C.

Publication type:

Article